R

Retina Research Center | Austin, TX

Research site

(Unclaimed)

Location

9707 Anderson Mill Road, Suite 100, Austin, Texas, United States of America

Site insights

Top conditions

Top treatments

Ranibizumab

Bevacizumab

Lampalizumab

Sunitinib Malate

Triamcinolone Acetonide

Pegcetacoplan

GB-102

-Ranibizumab

APL-2

Aflibercept

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 58 total trials

An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD (GALE)

This is a phase 3, open-label, multicenter, extension study to evaluate the long-term safety and efficacy of pegcetacoplan (APL-2) in subjects with g...

Active, not recruiting

Geographic Atrophy Secondary to Age-related Macular Degeneration

Drug: PEGCETACOPLAN (APL-2)

Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular Degeneration

Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (axitinib implant) in Subjects with Neovascular Age-Related Macular Degeneration

Enrolling

Neovascular Age-Related Macular Degeneration

Drug: OTX-TKI (axitinib implant)

Drug: Aflibercept

Trial sponsors

T

A

G

L

A

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms